Pfizer P/B Ratio
PFIZER • Price-to-Book ratio analysis and book value breakdown
Current P/B Ratio
5.55
High Valuation
Very High - Significant premium, high growth expectations or speculative
Current Valuation Metrics
P/B Ratio
5.55
Current Price
₹4887.10
Book Value/Share
₹916.74
Exchange
NSE
Book Value Breakdown (2025)
Balance Sheet Components
Total Equity
₹4,217 Cr
Share Capital
₹46 Cr
Reserves & Surplus
₹4,172 Cr
Outstanding Shares
46,000,000
Book Value per Share
₹916.74
Valuation Signal
Signal
Overvalued
Historical Avg
7.03
Historical Range
5.44 - 9.72
Percentile
20.0%
Sector Context
Sector Average
-0.19
Sector Median
0.64
Sector Rank
#11 of 50
Sector Percentile
22.0%
Key P/B Ratio Insights for Pfizer
- Stock appears overvalued with PB of 5.55, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 21.1% below historical average
- Trading at premium to sector average PB of -0.19
P/B Ratio Historical Trend for Pfizer
Historical P/B ratio trend based on balance sheet data. P/B below 1.0 may indicate undervaluation, while higher ratios suggest growth expectations or asset-light business models.
Related Pages for Pfizer
Additional stock information and data for PFIZER
Historical P/B Ratio Data
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 5.44 | ₹916.74 | ₹4987.70 | ₹4,217 | High |
| 2024 | 6.76 | ₹781.74 | ₹5281.50 | ₹3,596 | High |
| 2023 | 6.12 | ₹697.17 | ₹4268.95 | ₹3,207 | High |
| 2022 | 7.12 | ₹622.61 | ₹4431.70 | ₹2,864 | High |
| 2021 | 9.72 | ₹520.22 | ₹5055.30 | ₹2,393 | High |
Sector P/B Ratio Comparison
Comparing Pfizer with other companies in Healthcare sector
Sector Average
-0.19
Sector Median
0.64
Lowest P/B
-12.41
Highest P/B
1.04
Companies
50
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sun Pharma Advanced Rese… | SPARC | -12.41 | ₹3,972 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.47 | ₹95 | Low |
| Parmax Pharma | PARMAX | -2.15 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.96 | ₹154 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |